Stacie-Ann Sammott

Stacie-Ann Sammott

Auto-generated profile, based on publicly available information

Stacie-Ann Sammott

SUNY Stony Brook, Renaissance Sch Med, Stony Brook, NY USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2020 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
JAJeffrey E Alfonsi
Jeffrey E Alfonsi
ECElizabeth E Y Choi
Elizabeth E Y Choi
TATaha Arshad
Taha Arshad
SSStacie-Ann S Sammott
Stacie-Ann S Sammott
VPVanita Pais
Vanita Pais
MPMark R Palmert
Mark R Palmert
Background: Carbohydrate counting is an important component of diabetes management, but it is challenging, often performed inaccurately, and can be a barrier to optimal diabetes management. iSpy is a novel mobile app that leverages machine learning to allow food identification through images and that was designed to assist youth with type 1 diabetes in counting carbohydrates. Objective: Our objective was to test the app's usability and potential impact on carbohydrate counting accuracy. Methods: Iterative usability testing (3 cycles) was conducted involving a total of 16 individuals aged 8.5-17.0 years with type 1 diabetes. Participants were provided a mobile device and asked to complete tasks using iSpy app features while thinking aloud. Errors were noted, acceptability was assessed, and refinement and retesting were performed across cycles. Subsequently, iSpy was evaluated in a pilot randomized controlled trial with 22 iSpy users and 22 usual care controls aged 10-17 years. Primary outcome was change in carbohydrate counting ability over 3 months. Secondary outcomes included levels of engagement and acceptability. Change in HbA1c level was also assessed. Results: Use of iSpy was associated with improved carbohydrate counting accuracy (total grams per meal, P=.008), reduced frequency of individual counting errors greater than 10 g (P=.047), and lower HbA1c levels (P=.03). Qualitative interviews and acceptability scale scores were positive. No major technical challenges were identified. Moreover, 43% (9/21) of iSpy participants were still engaged, with usage at least once every 2 weeks, at the end of the study. Conclusions: Our results provide evidence of efficacy and high acceptability of a novel carbohydrate counting app, supporting the advancement of digital health apps for diabetes care among youth with type 1 diabetes. Further testing is needed, but iSpy may be a useful adjunct to traditional diabetes management. Trial Registration: ClinicalTrials.gov NCT04354142; https://clinicaltrials.gov/ct2/show/NCT04354142

21 March 2024 in Cancer Epidemiology
Verified
Journal Article
Open access
Aisha LoftersAisha Lofters
Aisha Lofters
SSStacie-Ann Sammott
Stacie-Ann Sammott
SSSarah Swayze
Sarah Swayze
JBJacqueline L. Bender
Jacqueline L. Bender
SAShabbir Alibhai
Shabbir Alibhai
GDGeetanjali Datta
Geetanjali Datta
Introduction: We previously identified specific immigrant groups (West African and Caribbean) with increased incidence of prostate cancer in Ontario, Canada. In this population -level retrospective cohort study, we used administrative databases to compare stage of diagnosis, 5 -year overall survival and prostate cancer -specific survival for immigrants versus long-term residents of Ontario. Methods: We linked several provincial -level databases available at ICES, an independent, non-profit research institute. We included all male Ontario residents 20 -105 years of age who had an incident prostate cancer diagnosis date between March 31, 2008 and March 31, 2017, stratified into immigrants vs. long-term residents. We used multivariable logistic regression to determine the odds of early (stage I -II) vs. late (III -IV) stage of diagnosis, adjusting for age, co -morbidities, neighbourhood income and continuity of care. We produced KaplanMeier curves for 5 -year overall survival and for 5 -year prostate cancer -specific survival. Results: Compared to long-term residents, men from West Africa (adjusted odds ratio 1.66 [95% CI 1.16 -2.38], East Africa (AOR 1.54 [95% CI 1.02 -2.33]) and the Caribbean (AOR 1.22 [95% CI 1.01 -1.47]) had a diagnostic stage advantage, and men from South Asia were most likely to be diagnosed at a late stage. In both unadjusted and adjusted analyses, overall and prostate cancer -specific survival were higher for immigrants than long-term residents. The highest five-year overall survival was seen for men from Sub-Saharan Africa and the Caribbean, and the lowest was seen for South Asian men, where 11.7% died within five years of diagnosis. Conclusion: Immigrant men in Ontario with prostate cancer are more likely to be diagnosed at an early stage and to survive for 5 years than long-term residents. Among immigrant men, men from the Caribbean and SubSaharan Africa have the greatest stage and survival advantage and South Asian men the least. Differences in awareness, diagnostic suspicion, genetic predisposition, and social factors may play a role in these findings.

10 July 2026 in University of Toronto Journal of Public Health
Verified
Journal Article
Open access
PDF file
ICIlakkiah Chandran
Ilakkiah Chandran
ESEmily Suthaharan
Emily Suthaharan
EOEsohe Ogbomo
Esohe Ogbomo
EGElijah Gyansa
Elijah Gyansa
SSStacie Sammot
Stacie Sammot
Aisha LoftersAisha Lofters
Aisha Lofters
Background: Breast cancer remains the most diagnosed cancer among women worldwide. Black women experience higher mortality rates, are more often diagnosed at advanced stages, and face persistent structural barriers to timely and equitable care. In the context of metastatic breast cancer, these inequities become even more pronounced. Despite this, the lived experiences and unmet care needs of Black women with metastatic disease have not been comprehensively synthesized. This narrative review examines the international literature to better understand these experiences and to identify ongoing gaps in care. Methods: A comprehensive search strategy was developed using OVID Medline and conducted across twelve databases. Peer-reviewed studies published in English that focused on the experiences, perceptions, or care needs of Black women with metastatic breast cancer were included. Editorials, commentaries, and studies not specific to metastatic disease were excluded. Three independent reviewers screened studies at the title, abstract, and full-text stages. Two reviewers completed data extraction and thematic synthesis. Results: Sixty studies met inclusion criteria; most originated from the United States, with additional studies from Canada, the United Kingdom, and several African countries. The included literature was comprised of qualitative studies, quantitative analyses, mixed-methods research, and clinical observational studies. Six interrelated themes emerged: cultural competence, personal beliefs and healthcare trust, healthcare navigation, discrimination and bias, support systems, and financial burden. Across studies, Black women described challenges rooted in structural inequities, limited culturally responsive care, healthcare system complexity, and experiences of discrimination. Conclusion: The experiences of Black women with metastatic breast cancer are shaped by intersecting structural and interpersonal barriers that influence care access, treatment experiences, and support. Evidence remains limited outside of the United States and parts of Africa. Further research is needed to more fully understand these disparities and to inform interventions that address the unmet needs of Black women living with metastatic disease.

2 July 2020 in JMIR Preprints
Verified
Preprint
Open access
JAJeffrey E Alfonsi
Jeffrey E Alfonsi
ECElizabeth E Y Choi
Elizabeth E Y Choi
TATaha Arshad
Taha Arshad
SSStacie-Ann S Sammott
Stacie-Ann S Sammott
VPVanita Pais
Vanita Pais
MPMark R Palmert
Mark R Palmert
BACKGROUND Carbohydrate counting is an important component of diabetes management, but it is challenging, often performed inaccurately, and can be a barrier to optimal diabetes management. iSpy is a novel mobile app that leverages machine learning to allow food identification through images and that was designed to assist youth with type 1 diabetes in counting carbohydrates. OBJECTIVE Our objective was to test the app's usability and potential impact on carbohydrate counting accuracy. METHODS Iterative usability testing (3 cycles) was conducted involving a total of 16 individuals aged 8.5-17.0 years with type 1 diabetes. Participants were provided a mobile device and asked to complete tasks using iSpy app features while thinking aloud. Errors were noted, acceptability was assessed, and refinement and retesting were performed across cycles. Subsequently, iSpy was evaluated in a pilot randomized controlled trial with 22 iSpy users and 22 usual care controls aged 10-17 years. Primary outcome was change in carbohydrate counting ability over 3 months. Secondary outcomes included levels of engagement and acceptability. Change in HbA1c level was also assessed. RESULTS Use of iSpy was associated with improved carbohydrate counting accuracy (total grams per meal, P=.008), reduced frequency of individual counting errors greater than 10 g (P=.047), and lower HbA1c levels (P=.03). Qualitative interviews and acceptability scale scores were positive. No major technical challenges were identified. Moreover, 43% (9/21) of iSpy participants were still engaged, with usage at least once every 2 weeks, at the end of the study. CONCLUSIONS Our results provide evidence of efficacy and high acceptability of a novel carbohydrate counting app, supporting the advancement of digital health apps for diabetes care among youth with type 1 diabetes. Further testing is needed, but iSpy may be a useful adjunct to traditional diabetes management. CLINICALTRIAL ClinicalTrials.gov NCT04354142; https://clinicaltrials.gov/ct2/show/NCT04354142